Cytokinetics Inc. (CYTK) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $62.99 -0.51%
EPS Growth %: +43.1%
Financial Fact:
Income tax benefit: 0
Today's EPS Names:
OPY, BNCC, ZVOI, More
EPS Growth %: +43.1%
Financial Fact:
Income tax benefit: 0
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Cytokinetics Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- AbbVie (ABBV) Tops Q3 EPS by 8c, Offers Guidance
- Iradimed Corp. (IRMD) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
